Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allevx is a topical analgesic patch formulated with a combination of lidocaine and menthol, primarily indicated for the temporary relief of minor aches and pains associated with arthritis, backache, strains, and sprains. Lidocaine, an amide-type local anesthetic, functions by blocking voltage-gated sodium channels in neuronal membranes, which inhibits the initiation and conduction of pain impulses. Menthol serves as a counterirritant and an agonist of the TRPM8 receptor, inducing a cooling sensation that helps to distract from deeper musculoskeletal discomfort. Developed and distributed by Method Pharmaceuticals, Allevx provides localized treatment with minimal systemic absorption, making it a preferred option for targeted pain management in an over-the-counter (OTC) setting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Allevx.